Literature DB >> 8611181

Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line.

L Miccoli1, S Oudard, F Sureau, F Poirson, B Dutrillaux, M F Poupon.   

Abstract

Hexokinase plays a key role in regulating cell energy metabolism. Hexokinase is mainly particulate, bound to the mitochondrial outer membrane in brain and tumour cells. We hypothesized that the intracellular pH (pH1) controls the intracellular distribution of hexokinase. Using the SNB-19 glioma cell line, pH1 variations were imposed by incubating cells in a high-K+ medium at different pH values containing specific ionophores (nigericin and valinomycin), without affecting cell viability. Subcellular fractions of cell homogenates were analysed for hexokinase activity. Imposed pH1 changes were verified microspectrofluorimetrically by using the pH1-sensitive probe SNARF-1-AM (seminaphtho-rhodafluor-1-acetoxymethyl ester). Imposition of an acidic pH1 for 30 min strongly decreased the particulate/total hexokinase ratio, from 63% in the control sample to 31%. Conversely, when a basic pH1, was imposed, the particulate/total hexokinase ratio increased to 80%. The glycolytic parameters, namely lactate/pyruvate ratio, glucose 6-phosphate and ATP levels, were measured concomitantly. Lactate/pyruvate ratio and ATP level were both markedly decreased by acidic pH1 and increased by basic pH1. Conversely, the glucose 6-phosphate level was increased by acidic pH1 and decreased by basic pH1. To demonstrate that the change of hexokinase distribution was not due to altered metabolite levels of glycolysis, a pH1 was imposed for a 5 min incubation time. Modification of the hexokinase distribution was similar to that noted after a 30 min incubation, whereas metabolite levels of glycolysis were not affected. These results provide evidence that the intracellular distribution of hexokinase is highly sensitive to variations of the pH1, and regulates hexokinase activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611181      PMCID: PMC1217004          DOI: 10.1042/bj3130957

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

Review 2.  Hexokinases and glucokinases.

Authors:  R J Middleton
Journal:  Biochem Soc Trans       Date:  1990-04       Impact factor: 5.407

Review 3.  Modulation of glycolysis in neuroepithelial tumors.

Authors:  A Floridi; M G Paggi; M Fanciulli
Journal:  J Neurosurg Sci       Date:  1989 Jan-Mar       Impact factor: 2.279

4.  J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential.

Authors:  M Reers; T W Smith; L B Chen
Journal:  Biochemistry       Date:  1991-05-07       Impact factor: 3.162

5.  Acid pH in tumors and its potential for therapeutic exploitation.

Authors:  I F Tannock; D Rotin
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

6.  Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.

Authors:  O Kaplan; G Navon; R C Lyon; P J Faustino; E J Straka; J S Cohen
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

7.  Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP.

Authors:  K K Arora; P L Pedersen
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

8.  Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells.

Authors:  M Board; S Humm; E A Newsholme
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

Review 9.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

10.  Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.

Authors:  J L Gross; D L Behrens; D E Mullins; P L Kornblith; D L Dexter
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

View more
  16 in total

1.  Light activation of the insulin receptor regulates mitochondrial hexokinase. A possible mechanism of retinal neuroprotection.

Authors:  Ammaji Rajala; Vivek K Gupta; Robert E Anderson; Raju V S Rajala
Journal:  Mitochondrion       Date:  2013-08-30       Impact factor: 4.160

2.  Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress.

Authors:  Manti Guha; Satish Srinivasan; Gopa Biswas; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

Review 3.  Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

Authors:  Saroj P Mathupala; Young H Ko; Peter L Pedersen
Journal:  Semin Cancer Biol       Date:  2008-12-03       Impact factor: 15.707

Review 4.  Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.

Authors:  S P Mathupala; Y H Ko; P L Pedersen
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

Review 5.  Cancer cell behaviors mediated by dysregulated pH dynamics at a glance.

Authors:  Katharine A White; Bree K Grillo-Hill; Diane L Barber
Journal:  J Cell Sci       Date:  2017-02-15       Impact factor: 5.285

Review 6.  Insulin, Muscle Glucose Uptake, and Hexokinase: Revisiting the Road Not Taken.

Authors:  David H Wasserman
Journal:  Physiology (Bethesda)       Date:  2021-11-15

Review 7.  Manipulating extracellular tumour pH: an effective target for cancer therapy.

Authors:  Guanyu Hao; Zhi Ping Xu; Li Li
Journal:  RSC Adv       Date:  2018-06-19       Impact factor: 4.036

8.  [F]fluoro-2-deoxy-d-glucose incorporation by mcf-7 breast tumour cells in vitro is modulated by treatment with tamoxifen, Doxorubicin, and docetaxel: relationship to chemotherapy-induced changes in ATP content, hexokinase activity, and glucose transport.

Authors:  R I Sharma; A E Welch; L Schweiger; S Craib; T A D Smith
Journal:  Int J Mol Imaging       Date:  2010-10-26

9.  Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation.

Authors:  F Poirson-Bichat; G Gonfalone; R A Bras-Gonçalves; B Dutrillaux; M F Poupon
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss.

Authors:  S Oudard; F Arvelo; L Miccoli; F Apiou; A M Dutrillaux; M Poisson; B Dutrillaux; M F Poupon
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.